Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan
β Scribed by Ken Shirabe; Takeo Toshima; Akinobu Taketomi; Kennichi Taguchi; Tomoharu Yoshizumi; Hideaki Uchiyama; Norifumi Harimoto; Kiyoshi Kajiyama; Akinori Egashira; Yoshihiko Maehara
- Book ID
- 111239581
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 426 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Aflatoxins are well-known animal hepatocarcinogens, but the association between aflatoxins and human hepatocellular carcinoma remains to be elucidated. A study method consisting of indirect immunofluorescence assay combined with densitometry was developed to quantitate aflatoxin B1 DNA adducts in sm
## Abstract Ξ²βCatenin plays a key role in the Wnt signaling pathway, and mutations of __CTNNB1__, the gene that encodes Ξ²βcatenin, have been identified in about oneβfourth of human hepatocellular carcinomas from regions of low aflatoxin B1 exposure. In this study 62 hepatocellular carcinomas (HCCs)
## Abstract Elevated aflatoxin B~1~βalbumin adducts (AFB~1~βAlb) have been associated with an increased risk for HCC development. However, there are no studies in humans, correlating albumin adducts in blood with liver DNA adducts. Forty frozen tumor tissues and 39 paired plasma samples from HCC pa